Amdocs (NASDAQ:DOX) Releases Quarterly Earnings Results, Misses Estimates By $0.19 EPS

Amdocs (NASDAQ:DOX) announced its quarterly earnings data on Tuesday. The technology company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.64 by ($0.19), Zacks reports. Amdocs had a net margin of 9.85% and a return on equity of 18.69%. Amdocs updated its Q2 2025 guidance to 1.670-1.730 EPS and its FY 2025 guidance to 6.859-7.116 EPS.

Amdocs Stock Performance

Shares of Amdocs stock traded down $1.39 on Thursday, reaching $86.76. 95,042 shares of the company traded hands, compared to its average volume of 595,754. Amdocs has a 52 week low of $74.41 and a 52 week high of $94.04. The company has a 50 day moving average of $85.96 and a 200 day moving average of $86.40. The firm has a market capitalization of $9.79 billion, a PE ratio of 20.42, a PEG ratio of 1.47 and a beta of 0.71. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.20 and a quick ratio of 1.20.

Amdocs Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Sunday, April 20th. Shareholders of record on Monday, March 31st will be given a $0.527 dividend. This represents a $2.11 dividend on an annualized basis and a yield of 2.43%. This is an increase from Amdocs’s previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. Amdocs’s dividend payout ratio is presently 45.28%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on DOX shares. StockNews.com upgraded shares of Amdocs from a “buy” rating to a “strong-buy” rating in a research report on Wednesday. Barclays decreased their target price on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research note on Thursday, November 14th. Finally, Oppenheimer boosted their target price on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $101.20.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.